Introduction

Retinitis pigmentosa (RP) is a heterogeneous group of hereditary diseases that affects photoreceptors and the retinal pigment epithelium. As most of the mutations lie in genes expressed in rod photoreceptors, the disease typically starts with island scotoma in the midperipheral visual field, and progresses to ring-shaped or concentric scotoma. In the very small central visual field left in advanced cases, some retain good function throughout the lifetime and others begin to degenerate, resulting in total blindness. Accurate and detailed measurement of the remaining function of cones or central macula is helpful not only for monitoring the progression of RP but also for future therapies.

There are several ways of monitoring macular function, including visual acuity (VA), contrast sensitivity, color vision, statistic visual field and electroretinogram (ERG). ERG is an objective measurement of retinal function that has been used for diagnosis and severity of the disease for many years. In contrast to conventional ERG, focal ERG (fERG) and multifocal ERG (mfERG) stimulate a small part of the retina and record the response from the area; these methods have advantage of monitoring macular function. The benefit of fERG1, 2, 3 and mf ERG4, 5, 6 in monitoring RP patients has already been reported.

Optical coherence tomography (OCT) is unique as it provides in vivo morphological information and has been used in many retinal disease, for example, macular oedema/thickening in various disease7 or retinal nerve fibre layer thinning in glaucoma.8 These studies coincidentally showed the close relationship between retinal function and its morphology. Some authors also studied OCT and mfERG and showed a correlation between mfERG amplitude and retinal thickness.9, 10, 11, 12 Since the time when OCT was used mainly to measure thickness of specific layer, the resolution of the image has been dramatically improved, and the device now can clearly recognize specific structure of the retina. Among the retinal structures observed with the latest model of OCT, the status of photoreceptor inner/outer segment junction (IS/OS), which is depicted as a high-intensity band just above the retinal pigment epithelium,8 is emerging as a useful parameter for monitoring macular morphology and function.13, 14, 15 Sandberg et al16 examined the retinal thickness and IS/OS in RP patients and reported that abnormal thickening or thinning of the retina and the absence of IS/OS are correlated with low VA. Similar results were also reported in Stargardt disease.17

OCT may provide practical, noninvasive, and less time-intensive means to monitor macular function of RP patients. In the present study, we examined whether OCT and fERG have any advantages as objective examinations in monitoring the progression of RP.

Materials and methods

Subjects

The subjects of this study included patients with RP who visited the Department of Ophthalmology, Kyoto University Hospital between November 2006 and April 2007. One eye of each patient was randomly included in the study. RP was diagnosed with the presence of night blindness, characteristic fundus appearance, concentric, ring-shaped or island scotoma corresponding to the fundus appearance, and nonrecordable or subnormal conventional ERG; conventional ERG was recorded according to the International Society for Clinical Electrophysiology of Vision (ISCEV) recommended in 2004. The patients with best-corrected VA worse than 0.1 (20/200), with myopia <−6 D, or with macular disease (eg, macular hole, epiretinal membrane or cystoid macular oedema) were excluded from the study.

The patients underwent an ophthalmic examination including best-corrected VA measurement, Goldmann perimetry, measurements with 3D OCT-1000 or its prototype Fourier domain OCT (Topcon, Tokyo, Japan) and fERG (Mayo corp., Inazawa, Japan). The examinations were performed within 3-month intervals. Six-millimeter horizontal macular scan was performed with OCT after patients' pupils were dilated. The obtained images were corrected for axial motion with standard algorithms of the manufacturer. These images were analysed by one of the authors (AO), who was masked from other examination results, and the patients were classified into three groups with the status of IS/OS. The classification was as follows: type 1, no IS/OS detected; type 2, IS/OS was depicted with OCT but the length was 2 mm of IS/OS was confirmed (Figure 1).

Figure 1
figure 1

Examples of classification used in the study. Type 1: photoreceptor inner segment/outer segment junction (IS/OS) was completely absent. Type 2: IS/OS is depicted with OCT but the length was less than 2 mm. Type 3: More than 2 mm of IS/OS was confirmed.

fERG was performed under the following setting: fERG was elicited by 15° stimulus positioned on the fovea and monitored by an infrared fundus camera. The luminance of white stimulus light and background illumination were 181.5 and 6.9 cd/m2, respectively. A background field of 45° visual angle was projected to the eye from the fundus camera. The Burian–Allen bipolar contact lens electrode was used for the fERG recordings. This electrode allowed not only low noise recordings but also permitted a clear view of the fundus that was displayed on a television monitor. The left ear served as a ground.

The fERGs were recorded with 5-Hz rectangular stimuli (100 ms light on and 100 ms light off) after patients' pupils were dilated. The stimulus spot was centred on the fovea. A total of 500 responses were averaged by a signal processor Neuropack MEB-2204 (Nihon Kohden, Tokyo, Japan). The fERG response was digitized at 10 kHz with a band-pass filter of 5–500 Hz for the a- and b-waves, and 50–500 Hz for OPs. The amplitudes and implicit times of the a- and b-waves, and the mean amplitudes and implicit times of the first three oscillatory potentials (OP1–OP3) were compared between the three types. The amplitude of the a-wave was measured from the baseline to the peak of the a-wave. The amplitude of the b-wave was measured from the trough of the a-wave to the peak of the b-wave. The amplitude of each OP wavelet was measured from a baseline to its peak. Results of the fERG responses were normalized by normal values obtained from age-matched 41 normal subjects.

The study always observed the tenets of the Declaration of Helsinki. Informed consent was obtained from each patient after full explanation of the examinations. We certify that all applicable institutional and governmental regulations concerning the ethical use of human volunteers were followed during this research.

Statistical analysis

The statistical program SPSS was used to analyse the sample data. The differences between each group were tested with one-way ANOVA followed by Bonferroni test. For the analysis of ERG implicit time, unpaired t-test was used since the majority of type 1 patients had nonrecordable ERG and implicit time could not be determined.

Results

The study sample consisted of 56 eyes of 56 patients, of whom 21 were men and 35 were women. IS/OS was not visible in 22 patients who were classified as type 1. All of the type 2 or 3 patients had IS/OS with the centre on fovea, and there was no single case with remaining IS/OS in peripheral macula but not in fovea. The demographics of the participants are shown in Table 1. There were no significant differences for average age (type 1: 46.6±17.4, type 2: 49.6±12.5, type 3: 52.4±17.1, years) or refractive error (type 1: −1.7+2.3, type 2: −1.8+2.0, and type 3: −0.8+2.9 D) between each group (Table 1).

Table 1 Demographics of patients in IS/OS subgroup

After every patient was successfully assigned to any one of each group, average logMAR of each group was compared; type 1 patients (0.4±0.3) had worse logMAR compared with type 2 (0.0±0.2) or 3 (0.0±0.2). The difference between types 2 and 3 was not statistically significant (Figure 2).

Figure 2
figure 2

LogMAR of each group. Type 1 had significantly lower logMAR compared with the other two groups (P<0.001). There was no significant difference between types 2 and 3.

Then, we analysed the fERG of each group. Almost all the patients classified as type 1 presented nonrecordable fERG (21/22), while only 3 patients out of 18 did so in type 2, and all patients were recordable in type 3 (Figure 3). The average b/a ratio were as follows: type 1, 4.3 (one case); type 2, 2.7±0.7; and type 3, 2.5±0.8, respectively. There was no negative fERG pattern in the examined patients. When comparing the normalized amplitude of a- and b-waves and oscillatory potential (OP), all waves showed progressive decline with the definition (P<0.001). The exact values of relative percentage to normal control were as follows: type 1, a-wave 1.1±5.3, b-wave 1.7±8.2, and OP 2.3±10.7; type 2, a-wave 42.2±29.1, b-wave 33.8±25.5, and OP 34.2±27.1; type 3, a-wave 81.1±24.7, b-wave: 73.7±23.5, and OP: 80.5±25.8 (Figure 4 left). However, the implicit time of each wave was not significantly different between types 2 and 3 (a-wave: 109.5±12.6 vs 102.8±9.0, P=0.074; b-wave: 103.2±5.0 vs 100.3±2.5, P=0.191; OP 104.9±7.6 vs 103.7±6.4, P=0.523) (Figure 4 right).

Figure 3
figure 3

Representative fERG results of each group, left: a- and b-wave, right: OP. While type 3 patients showed almost normal fERG, almost all the type 1 patients were nonrecordable.

Figure 4
figure 4

Left: The amplitude of fERG relative to the normal control (%) in each group. The amplitude of a-wave, b-wave, and OP declined in accordance with the definition with IS/OS. Right: The implicit time of fERG relative to the normal control (%) in each group. The result of type 1 could not be analysed since 21 patients out of 22 showed nonrecordable fERG. The difference between types 2 and 3 was not significant.

Discussion

Examinations that detect the subjective visual function are important, because these results directly correlate with the patient symptoms. VA and VF testing are the most widely used subjective measurements in clinical practice, and most clinical trials for eye diseases utilize these tests as major valuation bases. On the other hand, difficulties in clinical trials have been pointed out in that these measures of retinal function have inter-visit variability, and small changes can be overlooked in slowly progressive diseases such as RP.18 As cone photoreceptors can be lost in the fovea before having a reduction in VA19 and the neural degeneration is irreversible, more sensitive strategy or examination in detecting RP progression is necessary. In the present study, we evaluated the utility of the objective visual examination, OCT and fERG, as indicators of macular function in RP patients. We demonstrated that the evaluation of IS/OS depicted by OCT and measurement of cone function by fERG can be utilized as a strategy in judging the progression of RP.

IS/OS depicted with OCT is considered to represent the photoreceptor inner and outer segment junction.8 Distortion, shortening, or absence of IS/OS may indicate pathologic changes in photoreceptors as shown in RP16 as well as in macular hole,20 retinal detachment,14 retinal vein occlusion,21 central serous chorioretinopathy,13, 15, 22 or multiple evanescent white dot syndrome.23 Also in our patients, complete disappearance of IS/OS detected by OCT was correlated with decrease in VA, as expected. This supports the notion that morphological changes detected by OCT can reflect the function of fovea, also in RP patients. Shortening of IS/OS defined with a criteria more or less than 2 mm, which is based on the diameter of anatomical fovea 1.85 mm24 did not correlated with the VA decrease. This result may be reasonable as VA may represent the foveal function and both type 2 and 3 groups have IS/OS in fovea. In contrast, fERG detected the difference of the partial IS/OS shortening. The fERG amplitude was significantly different between the three IS/OS groups and of note, almost all the patients with absent IS/OS (21/22) showed nonrecordable fERG. Because fERG measures the 15° of macular area, the amplitude detected by fERG can represent the total macular function, which does not necessarily match with VA.25 OCT scans 6 mm of retina, which is approximately 20°, therefore, the shortening or absence of IS/OS is directly reflected as the decline in fERG amplitude.

In contrast to the amplitude, the implicit time of fERG of each group was not statistically different. When the photoreceptors degenerate, implicit time generally is elongated.26 The dissociation seen in the studied population may be due to the small sample size, or perhaps indicates that the photoreceptors are decreased in number, but the remaining cells function almost normally in the disease. Further study is needed to provide a precise answer to the process of cone degeneration in the disease.

This study was cross-sectional and has limitation in providing time course information. Absence or shortening of IS/OS observed with OCT was correlated with macular function, but we cannot tell whether it was the consequence of the disease progression or the phenotypic variation of the disease. In addition, we cannot predict which patient retains good macular function and which patient loses. Further study will be necessary to clarify this issue.

Finally, we showed that the status of IS/OS depicted with OCT is correlated well with VA and amplitude of fERG and that fERG detected the difference between types 2 and 3 patients who did not exhibit significant difference in VA. These data suggest that analysing the status of IS/OS with OCT may be a good strategy that represents both morphological and functional changes in RP. And fERG is another indicator of macular function for the patients without severe VA loss.